Autoimmune Dysautonomia Evaluation
Includes: AChR Ganglioninc Neuronal AB S, Anti-Neuronal Nuclear Ab Type 1, CASPR2-IgG CBA S, CRMP-5-IgG S, DPPX Ab IFA S, LGI1-IgG CBA S, Purkinje Cell Cytoplasmic Ab Type 2.
Reflexed Tests: AMPA-R Ab CBA S, AMPA-R IF Titer Assay S, Amphiphysin Ab S, Amphiphysin Immunoblot S, ANNA-1 Immunoblot S, ANNA-2 Immunoblot S, CRMP-5-IgG Western Blot S, DPPX Ab CBA S, DPPX AB IFA Titer S, GABA-B-R Ab CBA S, GABA-B-R Ab IF Titer Assay S, NMDA-R Ab CBA S, NMDA-R Ab IF Titer Assay S, PCA-1 Immunoblot S, PCA-Tr Immunoblot S, Purkinje Cell Cytoplasmic Ab Type 1, Purkinje Cell Cytoplasmic Ab Type Tr
x2
Tube Type
| Test ID |
|
LAB11401 |
EPIC ORDER
|
|
AUTOIMMUNE DYSAUTONOMIA EVALUATION, SERUM |
| CPT Code(s) |
|
83519, 86255x6 (83519, 84182x6, 86255x7, 86256x4, if appropriate) |
| Group/Individual Test |
|
Group |
| Laboratory |
|
Core Referral Testing |
| Tube Station |
|
30 |
| Specimen |
Routine: |
10 mL blood/red top/SST is acceptable; see comments |
| |
Micro: |
7.5 mL blood |
| Availability |
Routine: |
Reference Laboratory - Mayo Clinic Laboratories |
| Turnaround Time |
|
12-14 days |
| Reference Range |
Normal: |
See separate report |
| Comments |
|
1. For optimal antibody detection, specimen collection is recommended before initiation of immunosuppressant medication or intravenous immunoglobulin treatment.
2. This test should not be requested in patients who have recently received radioisotopes, therapeutically or diagnostically, because of potential assay interference. The specific waiting period before specimen collection will depend on the isotope administered, the dose given, and the clearance rate is the individual patient. Specimens will be screened for radioactivity prior to analysis. Radioactive specimens received int he laboratory will be held 1 week and assayed if sufficiently decayed, or canceled or radioactivity remains.
3. Patient should have no general anestetic or muscle-relaxant medications in the previous 24 hours.
|
|
|
|
